Biosci. Biotechnol. Biochem., 71 (10), 2592–2595, 2007
Note
2-epi-Botcinin A and 3-O-Acetylbotcineric Acid from Botrytis cinerea
Emi S AKUNO, Hiroko T ANI,* and Hiromitsu N AKAJIMAy
Department of Agricultural Chemistry, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan
Received May 30, 2007; Accepted June 19, 2007; Online Publication, October 7, 2007
[doi:10.1271/bbb.70334]
Two metabolites, 2-epi-botcinin A and 3-O-acetylbotcineric acid, were isolated from Botrytis cinerea
(AEM211). The former compound was new, and the
latter was known but structurally revised by us. In a test
for antifungal activity against Magnaporthe grisea, a
pathogen of rice blast disease, 2-epi-botcinin A was 8
times less active than botcinin A (MIC 100 M), and the
MIC value for 3-O-acetylbotcineric acid being 100 M.
Key words:
2-epi-botcinin A; 3-O-acetylbotcineric acid;
Botrytis cinerea; antifungal activity; Magnaporthe grisea
Botrytis cinerea is a phytopathogen causing serious
gray mold disease in many kinds of cultivated plants.
The fungus produces many structurally diverse metabolites1–18) and is particularly well known as a producer
of abscisic acid, a plant hormone.13) We have recently
reported the isolation of new metabolites, botcinins A
(1), B (2), C (3), D, E, and F, and the known metabolite,
botcinolide, from an ethyl acetate extract of a strain of
B. cinerea (AEM211) and their antifungal activity
against Magnaporthe grisea, a pathogen of rice blast
disease.19,20) In our previous study, the botcinins were
shown to have a unique bicyclic unit and a fatty acyl
portion, and we thoroughly reinvestigated the structure
of botcinolide with a view to its structural relationship to
botcinins. As a result, the structure of botcinolide (5) has
been revised from a 9-membered macrolide to the seco
acid of botcinin E (7), and botcinolide has been renamed
botcinic acid. Homobotcinolide (6), a botcinolide analogue, has also been structurally revised to 8 and
renamed botcineric acid.20)
Our continuing search for new botcinins resulted in
the isolation of a new botcinin and a known 3-Oacetylhomobotcinolide21) which was structurally revised
to a botcineric acid analogue by precise interpretation of
its spectroscopic data and its conversion to a known
compound. We report in this paper the isolation and
structure of 2-epi-botcinin A (4) and 3-O-acetylbotcineric acid (9) and describe their antifungal activity.
Botrytis cinerea AEM 211, which had been isolated
from a diseased strawberry in Tottori Prefecture,19) was
y
*
O
O
CH3
H
1
3'
O
CH
OAc 3
R1
CH3
CH3
H
H
1:
2:
3:
4:
HO
HO
H3C
HO
5'
7'
O
CH3
3
R1
R3
1'
7
5
R2
OH
O
R2
H
H
CH3
CH3
R3
CH3
(CH2)2CH3
(CH2)2CH3
CH3
CH3
OH
R
O
5
7
3
1
H3C
O
CH3
O
O
R
5: CH3
6: (CH2)2CH3
CH3
HO
HO
CH3
1
O
R1
7: H
8: H
9: Ac
3
OH
O
5
O
CH3
OR1
R2
1'
7
3'
5'
7'
O
CH3
R2
CH3
(CH2)2CH3
(CH2)2CH3
Fig. 1. Structures of Botcinins A (1), B (2), C (3), 2-epi-Botinin A
(4), Botcinic Acid (7), Botcineric Acid (8), and 3-O-Acetylbotcineric Acid (9).
cultured on a malt extract medium, without shaking, at
24 C for 14 days in the dark. The metabolites in the
culture filtrate were extracted with ethyl acetate and
separated into neutral and acidic fractions. The neutral
fraction was purified by chromatographic separation to
afford two anisaldehyde-positive compounds, 4 and 9, in
respective yields of 1.1 and 0.7 mg/l.
Compound 4 was obtained as an amorphous solid.
The HRFABMS and NMR data for 4 afforded the
To whom correspondence should be addressed. Tel/Fax: +81-857-31-5362; E-mail: nakajima@muses.tottori-u.ac.jp
Present address: Yamada Bee Farm, Institute for Bee Products & Health, Kagamino-cho, Tomada-gun, Okayama 708-0393, Japan
Botcinin Analogues Produced by Botrytis cinerea
Table 1.
1
H- and
13
2593
C-NMR Data for Compounds 4 and 9 in CDCl3
4
Position
C
1
2
2-CH3
3
4
4-CH3
5
6
6-CH3
7
8
8-CH3
10
20
30
40
50
60
70
80
90
100
CH3 CO
172.4
42.0
16.5
77.9
73.1
10.1
79.4
35.3
13.5
76.3
68.2
18.1
165.6
119.0
151.8
71.1
36.4
27.3
22.5
13.9
20.9
170.0
9
H (mult., J in Hz)
C
2.61 (dq, J ¼ 7:8, 7.3)
1.43 (d, J ¼ 7:3)
4.96 (d, J ¼ 7:8)
1.33
3.71
2.11
1.07
4.52
3.68
1.07
(s)
(d, J ¼ 11:2)
(ddq, J ¼ 10:1, 11.2, 6.2)
(d, J ¼ 6:2)
(dd, J ¼ 10:1, 10.1)
(dq, J ¼ 10:1, 6.2)
(d, J ¼ 6:2)
6.06 (dd, J ¼ 1:6, 15.6)
7.01 (dd, J ¼ 4:6, 15.6)
4.33 (m)
1.53–1.65 (m)
1.24–1.39 (m)
1.24–1.39 (m)
0.91 (t, J ¼ 7:1)
2.11 (s)
molecular formula of C22 H34 O8 . The 1 H-NMR and 13 CNMR data for 4 (Table 1) mostly agreed with those for
botcinin C (3, C24 H38 O8 ), although two signals assignable to the methylene carbons of the acyl side chain
were lost in the 13 C-NMR data for 4,19) indicating that
compound 4 had two fewer methylenes than 3 in the
acyl portion. The partial structure of CO–CH=CH–
CH(OH)– in the acyl portion of 4 and E geometry of the
double bond was confirmed by the 1 H-NMR data. The
fragment ion assignable to the acyl portion was also
observed at m=z 169 in the EIMS spectrum of 3 and at
m=z 141 in that of 4. The relative stereochemistry of the
ring portion of 4 was suggested to be identical to that of
3 by the NOE correlations. Irradiation of the 4-methyl
protons caused enhancement in the resonances of H-2
and H-8, whereas no effect was apparent on H-5. The
effect on H-6 by irradiating the 4-methyl protons was
not clear due to overlapping of the acetyl methyl
resonance. Irradiation of H-5 produced NOE in the
resonances of H-3 and H-7. The optical rotation values
for 3 and 4, ½ 25 D 28 and ½ 25 D 31 , respectively,
were almost the same, indicating that the absolute
stereochemistry of 3 and 4 was probably the same.
Compound 4 differs from botcinin A (1) only by the
stereochemistry at C-2 and thus is identical to 2-epibotcinin A.
Compound 9 was isolated as a colorless oil. The
molecular formula of 9 was deduced as C24 H40 O9 from
NMR and FABMS data, which showed the ½M þ Naþ
and ½M þ Hþ ions at m=z 495 and 473, respectively.
The 1 H- and 13 C-NMR data for 9 (Table 1) were similar
to those for botcinin B, C24 H38 O8 (2), except for some
172.9
40.0
17.3
77.8
79.8
14.8
71.1
37.0
14.0
75.7
69.5
17.5
165.7
119.0
151.8
71.1
36.7
25.2
29.1
31.7
22.5
14.0
20.9
172.5
H
3.09 (dq, J ¼ 1:6, 7.4)
1.28 (d, J ¼ 7:4)
4.95 (d, J ¼ 1:6)
1.40
3.11
1.95
1.00
4.50
3.77
1.17
(s)
(d, J ¼ 10:8)
(ddq, J ¼ 10:8, 10.8, 6.4)
(d, J ¼ 6:4)
(dd, J ¼ 9:9, 10.8)
(dq, J ¼ 9:9, 6.0)
(d, J ¼ 6:0)
6.06 (dd, J ¼ 1:6, 15.6)
6.99 (dd, J ¼ 4:6, 15.6)
4.34 (m)
1.60 (m)
1.37–1.43 (m)
1.25–1.34 (m)
1.25–1.34 (m)
1.25–1.34 (m)
0.88 (t, J ¼ 6:9)
2.23 (s)
differences in chemical shifts. In the 13 C-NMR spectrum
of 9, C-2, C-3, C-4, C-5, 2-CH3 , and 4-CH3 resonances
were observed 2.8 ppm downfield, 3.5 ppm downfield,
4.6 ppm downfield, 7.4 ppm upfield, 7.1 ppm downfield,
and 2.9 ppm downfield, respectively, compared to that of
botcinin B. These shifts were due to the disappearance
of the lactone ring. To verify this speculation, we treated
9 with acetic anhydride and pyridine to afford an
acetylated and lactonized product, this being identical in
all respects, including optical rotation, to the compound
obtained by acetylating botcinin B. Thus, 9 was identified as 3-O-acetylbotcineric acid, and the absolute
configuration was assigned as 2R, 3S, 4S, 5S, 6S, 7R, 8S,
40 S. The 1 H-NMR data for 9 agreed well with those
reported for 3-O-acetylhomobotcinolide21) in the same
solvent. 3-O-Acetylhomobotcinolide should be revised
structurally to 3-O-acetylbotcineric acid.
Compounds 4 and 9 were tested for their antifungal
activity against Magnaporthe grisea. The MIC value for
compound 4 was 800 mM, while those for botcinin A (1),
B (2), and C (3) were 100 mM, 12.5 mM, and 100 mM,
respectively.19) Compounds 4 and 3 are 2-epimers of 1
and 2, respectively. Compounds 2 and 3 each have a C10
acyl portion, while compounds 1 and 4 have a C8 acyl
portion. Thus, in C-2, the R configuration produced
enhancement of the antifungal activity compared with
the S configuration, the length of the acyl chain also
being important for the activity. The MIC value for
compound 9, the seco acid of botcinin B, was 100 mM.
We had previously reported the MIC value for botcinic
acid (7) as 100 mM, but this did not show antifungal
activity even at 800 mM in this study. This unexpected
2594
E. SAKUNO et al.
result suggested a problem with the sample used in the
assay. We therefore collected the NMR data for the
sample and then confirmed the identity and purity of the
sample. At the same time, the assay on the sample was
repeated again and again, but no activity could be found,
even at 800 mM. The reason why botcinic acid showed a
100 mM MIC value in the previous experiment is still not
clear. The antifungal activity of 9 and botcinic acid (7)
suggest that the length of the acyl chain and/or the
acetoxyl group in C-3 in botcinic acid analogues was
important for their activity. Many botcinic acid analogues need to be tested before determining the relationship between the antifungal activity and structure.
Experimental
General information. Optical rotation values were
measured with a Horiba SEPA-200 polarimeter. UV
spectra were recorded with a Hitachi U-2001 spectrophotometer, and IR spectra with a Jasco FT/IR 7000
spectrometer. NMR spectra were measured with a Jeol
JNM-ECP 500 spectrometer. Chemical shifts were
referenced to CDCl3 (H 7.26, C 77.0). Mass spectra
were obtained with a Jeol AX505HA spectrometer
(direct probe). p-Nitrobenzyl alcohol was the matrix
used for FABMS, and the reaction gas for CIMS was
isobutane. HPLC was carried out in a Cosmosil 5C18 AR column (Nacalai Tesque, 10 250 mm), using 75%
MeOH in 1% AcOH as the eluent at a flow rate of
1.0 ml/min, with detection at 220 nm. Merck Kieselgel
60 F254 was used for TLC. The spots on TLC plates were
detected by spraying the anisaldehyde-sulfuric acid
reagent onto the plate and heating it at 110 C for
20 min. The spray reagent was prepared flesh before use
by adding 1 ml of concentrated H2 SO4 to a solution of
0.5 ml of p-anisaldehyde in 50 ml of acetic acid.
Fermentation and isolation. The fungus was grown
without shaking at 24 C for 14 days in the dark in 500ml conical flasks (50) containing a liquid medium
(200 ml/flask) composed of glucose (30 g/l), peptone
(3 g/l), the extract from 50 g/l of malt, and tap water.
Metabolites were extracted from the culture filtrate with
EtOAc (3 10-liter) after adjusting the pH value to 2.0
with 6 M HCl. The EtOAc solution was washed with 1 M
NaHCO3 (2 0:5 volume), dried over Na2 SO4 , and
concentrated to dryness to give a residue (5.2 g). This
residue was subjected to silica gel column chromatography (Daiso gel IR-60, 31 200 mm), with 1200 ml
(240 ml 5) each of 10%, 20%, 30% and 40% acetone
in n-hexane as the eluent. The third fraction (186 mg),
eluted with 20% acetone in n-hexane, was purified by
Sephadex LH-20 column chromatography (20 900
mm, MeOH). Five-milliliter portions of the eluate were
collected. Fractions 12–33 were combined and purified
further by HPLC to give compound 4 (11 mg, Rt
34 min). Fractions 1–3 (249 mg) of 30% acetone in nhexane were subjected to ODS flash column chromatography (Cosmosil 75C18 -PREP, 22 75 mm), with
150 ml (10 ml 15) each of 50%, 60%, 70%, and 80%
MeOH as the eluent. Fractions 3–5 of 60% MeOH were
combined and purified by HPLC to give compound 9
(7 mg, Rt 64 min).
2-epi-Botcinin A (4). Amorphous solid. ½ 25 D 31
(c 0.26, EtOH). UV max (EtOH) nm ("): 214 (12,700).
IR (KBr) max cm1 : 3446, 2940, 2878, 1752, 1729.
NMR data: see Table 1. FABMS m=z 427 ðM þ HÞþ .
HRFABMS m=z ðM þ HÞþ : calcd. for C22 H35 O8 ,
427.2332; found, 427.2334.
3-O-Acetylbotcineric acid (9). Colorless oil. ½ 25 D
5:20 (c 0.5, EtOH). UV max (EtOH) nm ("): 212
(14,800). NMR data: see Table 1. FABMS m=z: 495
ðM þ NaÞþ , 473 ðM þ HÞþ .
Antifungal test. The antifungal activities of the
metabolites were determined by using the procedures
previously reported.19)
References
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
11)
12)
13)
Fehlhaber, H.-W., Geipel, R., Mercker, H.-J., Tschesche,
R., Welmar, K., and Schönbeck, F., Botrydial, ein
sesquiterpen-antibiotikum aus der nährlösung des pilzes
Botrytis cinerea. Chem. Ber., 107, 1720–1730 (1974).
Bradshaw, A. P. W., and Hanson, J. R., Three new
sesquiterpenoid metabolites of Botrytis cinerea. J. Chem.
Soc., Perkin Trans. 1, 741–743 (1980).
Collado, I. G., Hernández-Galán, R., Durán-Patrón, R.,
and Cantoral, J. M., Metabolites from a shake culture of
Botrytis cinerea. Phytochemistry, 38, 647–650 (1995).
Durán-Patrón, R., Hernández-Galán, R., Rebordinos, L.
G., Cantoral, J. M., and Collado, I. G., Structure-activity
relationships of new phytotoxic metabolites with the
botryane skeleton from Botrytis cinerea. Tetrahedron,
55, 2389–2400 (1999).
Durán-Patrón, R., Hernández-Galán, R., and Collado, I.
G., Secobotrytriendiol and related sesquiterpenoids: new
phytotoxic metabolites from Botrytis cinerea. J. Nat.
Prod., 63, 182–184 (2000).
Durán-Patrón, R., Colmenares, A. J., Hernández-Galán,
R., and Collado, I. G., Some key metabolic intermediates
in the biosynthesis of botrydial and related compounds.
Tetrahedron, 57, 1929–1933 (2001).
Colmenares, A. J., Durán-Patrón, R. M., HernándezGalán, R., and Collado, I. G., Four new lactones from
Botrytis cinerea. J. Nat. Prod., 65, 1724–1726 (2002).
Arpin, N., Favre-Bonvin, J., and Thivend, S., Structure
de la mycosporine 2, nouvelle molecule, isolee de
Botrytis cinerea. Tetrahedron Lett., 819–820 (1977).
Arpin, N., Curt, R., and Favre-Bonvin, J., Mycosporines:
review and new data concerning their structure. Rev.
Mycol., 43, 247–257 (1979).
Filimonova, M. V., Biologically active substances of the
fungus Botrytis cinerea Pers. Prikl. Biokhim. Mikrobiol.,
21, 707–713 (1985).
Welmar, K., Tschesche, R., and Breitmaier, E., Botrylacton, ein neuer wirkstoff aus der nährlösung des pilzes
Botrytis cinerea, 2. Chem. Ber., 112, 3598–3602 (1979).
Bruns, W., Horns, S., and Redlich, H., Botrylactone
synthesis and structure revision: a convergent approach
from D-glucose. Synthesis, 335–342 (1995).
Marumo, S., Katayama, M., Komori, E., Ozaki, Y.,
Botcinin Analogues Produced by Botrytis cinerea
14)
15)
16)
17)
Natsume, M., and Kondo, S., Microbial production of
abscisic acid by Botrytis cinerea. Agric. Biol. Chem., 46,
1967–1968 (1982).
Cutler, H. G., Springer, J. P., Arrendale, R. F., Arison, B.
H., Cole, P. D., and Roberts, R. G., Cinereain: a novel
metabolite with plant growth regulating properties from
Botrytis cinerea. Agric. Biol. Chem., 52, 1725–1733
(1988).
Cutler, H. G., Jacyno, J. M., Harwood, J. S., Dulik, D.,
Goodrich, P. D., and Roberts, R. G., Botcinolide: a
biologically active natural product from Botrytis cinerea.
Biosci. Biotechnol. Biochem., 57, 1980–1982 (1993).
Jacyno, J. M., Harwood, J. S., Cutler, H. G., and Dulik,
D. M., Structure and solution-state conformation of
botcinolide, a new biologically active metabolite from
the fungus Botrytis cinerea. Tetrahedron, 50, 11585–
11592 (1994).
Cutler, H. G., Parker, S. R., Ross, S. A., Crumley, F. G.,
and Schreiner, P. R., Homobotcinolide: a biologically
active natural homolog of botcinolide from Botrytis
18)
19)
20)
21)
2595
cinerea. Biosci. Biotechnol. Biochem., 60, 656–658
(1996).
Collado, I. G., Aleu, J., Hernández-Galán, R., and
Hanson, J. R., Some metabolites of Botrytis cinerea
related to botcinolide. Phytochemistry, 42, 1621–1624
(1996).
Tani, H., Koshino, H., Sakuno, E., and Nakajima, H.,
Botcinins A, B, C, and D, metabolites produced by
Botrytis cinerea, and their antifungal activity against
Magnaporthe grisea, a pathogen of rice blast disease.
J. Nat. Prod., 68, 1768–1772 (2005).
Tani, H., Koshino, H., Sakuno, E., Cutler, H. G., and
Nakajima, H., Botcinins E and F and botcinolide from
Botrytis cinerea and structural revision of botcinolides.
J. Nat. Prod., 69, 722–725 (2006).
Reino, J. L., Durán-Patrón, R. M., Daoubi, M., Collado,
I. G., and Hernández-Galán, R., Biosynthetic studies on
the botcinolide skeleton: new hydroxylated lactones
from Botrytis cinerea. J. Org. Chem., 71, 562–565
(2006).